<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37704012</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1090-2139</ISSN><JournalIssue CitedMedium="Internet"><Volume>114</Volume><PubDate><Year>2023</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Brain, behavior, and immunity</Title><ISOAbbreviation>Brain Behav Immun</ISOAbbreviation></Journal><ArticleTitle>Plasma proteomics show altered inflammatory and mitochondrial proteins in patients with neurologic symptoms of post-acute sequelae of SARS-CoV-2 infection.</ArticleTitle><Pagination><StartPage>462</StartPage><EndPage>474</EndPage><MedlinePgn>462-474</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbi.2023.08.022</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0889-1591(23)00253-2</ELocationID><Abstract><AbstractText>Persistent symptoms of COVID-19 survivors constitute long COVID syndrome, also called post-acute sequelae of SARS-CoV-2 infection (PASC). Neurologic manifestations of PASC (Neuro-PASC) are particularly debilitating, long lasting, and poorly understood. To gain insight into the pathogenesis of PASC, we leveraged a well-characterized group of Neuro-PASC (NP) patients seen at our Neuro-COVID-19 clinic who had mild acute COVID-19 and never required hospitalization to investigate their plasma proteome. Using the SomaLogic platform, SomaScan, the plasma concentration of &gt;7000 proteins was measured from 92 unvaccinated individuals, including 48 NP patients, 20 COVID-19 convalescents (CC) without lingering symptoms, and 24 unexposed healthy controls (HC) to interrogate underlying pathobiology and potential biomarkers of PASC. We analyzed the plasma proteome based on post-COVID-19 status, neurologic and non-neurologic symptoms, as well as subjective and objective standardized tests for changes in quality-of-life (QoL) and cognition associated with Neuro-PASC. The plasma proteome of NP patients differed from CC and HC subjects more substantially than post-COVID-19 groups (NP and CC combined) differed from HC. Proteomic differences in NP patients 3-9&#xa0;months following acute COVID-19 showed alterations in inflammatory proteins and pathways relative to CC and HC subjects. Proteomic associations with Neuro-PASC symptoms of brain fog and fatigue included changes in markers of DNA repair, oxidative stress, and neutrophil degranulation. Furthermore, we discovered a correlation between NP patients lower subjective impression of recovery to pre-COVID-19 baseline with an increase in the concentration of the oxidative phosphorylation protein COX7A1, which was also associated with neurologic symptoms and fatigue, as well as impairment in QoL and cognitive dysfunction. Finally, we identified other oxidative phosphorylation-associated proteins correlating with central nervous system symptoms. Our results suggest ongoing inflammatory changes and mitochondrial involvement in Neuro-PASC and pave the way for biomarker validation for use in monitoring and development of therapeutic intervention for this debilitating condition.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hanson</LastName><ForeName>Barbara A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Visvabharathy</LastName><ForeName>Lavanya</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orban</LastName><ForeName>Zachary S</ForeName><Initials>ZS</Initials><AffiliationInfo><Affiliation>Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jimenez</LastName><ForeName>Millenia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Batra</LastName><ForeName>Ayush</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liotta</LastName><ForeName>Eric M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeLisle</LastName><ForeName>Robert K</ForeName><Initials>RK</Initials><AffiliationInfo><Affiliation>SomaLogic, Inc, Boulder, CO 80301, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klausner</LastName><ForeName>Jeffrey D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cohen</LastName><ForeName>Pinchas</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>The Leonard Davis School of Gerontology, University of Southern California, Los Angeles, CA 90089, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Padhye</LastName><ForeName>Advait S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Antisense Therapeutics Limited, Toorak, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tachas</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Antisense Therapeutics Limited, Toorak, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koralnik</LastName><ForeName>Igor J</ForeName><Initials>IJ</Initials><AffiliationInfo><Affiliation>Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA. Electronic address: Igor.Koralnik@northwestern.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 AG078705</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG069698</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Brain Behav Immun</MedlineTA><NlmUniqueID>8800478</NlmUniqueID><ISSNLinking>0889-1591</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D024101">Mitochondrial Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020543">Proteome</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024101" MajorTopicYN="Y">Mitochondrial Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020543" MajorTopicYN="N">Proteome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">COX7A1</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Mitochondrial dysfunction</Keyword><Keyword MajorTopicYN="N">Neurologic symptoms</Keyword><Keyword MajorTopicYN="N">Oxidative phosphorylation</Keyword><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">Post-acute sequelae of SARS-CoV-2 infection</Keyword><Keyword MajorTopicYN="N">Proteomics</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>1</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>14</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>13</Day><Hour>19</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37704012</ArticleId><ArticleId IdType="mid">NIHMS1948462</ArticleId><ArticleId IdType="pmc">PMC10718560</ArticleId><ArticleId IdType="doi">10.1016/j.bbi.2023.08.022</ArticleId><ArticleId IdType="pii">S0889-1591(23)00253-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ahmad AS, Ottallah H, Maciel CB, Strickland M, Dore S, 2019. Role of the L-PGDS-PGD2-DP1 receptor axis in sleep regulation and neurologic outcomes. Sleep 42 (6). 10.1093/sleep/zsz073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/sleep/zsz073</ArticleId><ArticleId IdType="pmc">PMC6559173</ArticleId><ArticleId IdType="pubmed">30893431</ArticleId></ArticleIdList></Reference><Reference><Citation>Akgun E, Tuzuner MB, Sahin B, Kilercik M, Kulah C, Cakiroglu HN, Serteser M, Unsal I, Baykal AT, Palaniyar N, 2020. Proteins associated with neutrophil degranulation are upregulated in nasopharyngeal swabs from SARS-CoV-2 patients. PLoS One 15 (10), e0240012. 10.1371/journal.pone.0240012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240012</ArticleId><ArticleId IdType="pmc">PMC7575075</ArticleId><ArticleId IdType="pubmed">33079950</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali ST, Kang AK, Patel TR, et al., 2022. Evolution of neurologic symptoms in non-hospitalized COVID-19 &#x201c;long haulers&#x201d;. Ann. Clin. Transl. Neurol. 9 (7), 950&#x2013;961. 10.1002/acn3.51570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51570</ArticleId><ArticleId IdType="pmc">PMC9268866</ArticleId><ArticleId IdType="pubmed">35607826</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey J, Lavelle B, Miller J, et al., 2023. Multidisciplinary center care for long COVID syndrome - a retrospective cohort study. Am. J. Med 10.1016/j.amjmed.2023.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2023.05.002</ArticleId><ArticleId IdType="pmc">PMC10200714</ArticleId><ArticleId IdType="pubmed">37220832</ArticleId></ArticleIdList></Reference><Reference><Citation>Captur G, Moon JC, Topriceanu C-C, Joy G, Swadling L, Hallqvist J, Doykov I, Patel N, Spiewak J, Baldwin T, Hamblin M, Menacho K, Fontana M, Treibel TA, Manisty C, O&#x2019;Brien B, Gibbons JM, Pade C, Brooks T, Altmann DM, Boyton RJ, McKnight &#xc1;, Maini MK, Noursadeghi M, Mills K, Heywood WE, 2022. Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection. EBioMedicine 85, 104293. 10.1016/j.ebiom.2022.104293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104293</ArticleId><ArticleId IdType="pmc">PMC9515404</ArticleId><ArticleId IdType="pubmed">36182629</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi H, Yao R, Sun C, Leng B, Shen T, Wang T, Zhang S, Li M, Yang Y, Sun H, Li Z, Zhang J, 2022. Blood neuroexosomal Mitochondrial Proteins Predict Alzheimer disease in diabetes. Diabetes. 71 (6), 1313&#x2013;1323. 10.2337/db21-0969.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db21-0969</ArticleId><ArticleId IdType="pubmed">35287177</ArticleId></ArticleIdList></Reference><Reference><Citation>Choong C-J, Okuno T, Ikenaka K, Baba K, Hayakawa H, Koike M, Yokota M, Doi J, Kakuda K, Takeuchi T, Kuma A, Nakamura S, Nagai Y, Nagano S, Yoshimori T, Mochizuki H, 2021. Alternative mitochondrial quality control mediated by extracellular release. Autophagy 17 (10), 2962&#x2013;2974. 10.1080/15548627.2020.1848130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2020.1848130</ArticleId><ArticleId IdType="pmc">PMC8525996</ArticleId><ArticleId IdType="pubmed">33218272</ArticleId></ArticleIdList></Reference><Reference><Citation>de Las Heras N, Martin Gimenez VM, Ferder L, Manucha W, Lahera V 2020. Implications of oxidative stress and potential role of mitochondrial dysfunction in COVID-19: therapeutic effects of vitamin D. Antioxidants (Basel). 9(9). Doi: 10.3390/antiox9090897.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9090897</ArticleId><ArticleId IdType="pmc">PMC7555731</ArticleId><ArticleId IdType="pubmed">32967329</ArticleId></ArticleIdList></Reference><Reference><Citation>Demichev V, Tober-Lau P, Lemke O, et al., 2021. A time-resolved proteomic and prognostic map of COVID-19. Cell Syst. 12 (8), 780&#x2013;794 e7. 10.1016/jcels.2021.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/jcels.2021.05.005</ArticleId><ArticleId IdType="pmc">PMC8201874</ArticleId><ArticleId IdType="pubmed">34139154</ArticleId></ArticleIdList></Reference><Reference><Citation>Denaro CA, Haloush YI, Hsiao SY, et al., 2022. COVID-19 and neurodegeneration: The mitochondrial connection. Aging Cell. 21 (11), e13727 10.1111/acel.13727.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.13727</ArticleId><ArticleId IdType="pmc">PMC9649608</ArticleId><ArticleId IdType="pubmed">36219531</ArticleId></ArticleIdList></Reference><Reference><Citation>Durstenfeld MS, Sun K, Tahir P, Peluso MJ, Deeks SG, Aras MA, Grandis DJ, Long CS, Beatty A, Hsue PY, 2022. Use of cardiopulmonary exercise testing to evaluate long COVID-19 symptoms in adults: A systematic review and meta-analysis. JAMA Netw. Open 5 (10), e2236057. 10.1001/jamanetworkopen.2022.36057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.36057</ArticleId><ArticleId IdType="pmc">PMC9557896</ArticleId><ArticleId IdType="pubmed">36223120</ArticleId></ArticleIdList></Reference><Reference><Citation>El Chehadeh S, Han KA, Kim D, Jang G, Bakhtiari S, Lim D, Kim HY, Kim J, Kim H, Wynn J, Chung WK, Vitiello G, Cutcutache I, Page M, Gecz J, Harper K, Han A-R, Kim HM, Wessels M, Bayat A, Ja&#xe9;n AF, Selicorni A, Maitz S, de Brouwer APM, Silfhout A-V, Armstrong M, Symonds J, K&#xfc;ry S, Isidor B, Cogn&#xe9; B, Nizon M, Feger C, Muller J, Torti E, Grange DK, Willems M, Kruer MC, Ko J, Piton A, Um JW, 2022. SLITRK2 variants associated with neurodevelopmental disorders impair excitatory synaptic function and cognition in mice. Nat. Commun 13 (1), 4112 10.1038/s41467-022-31566-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-31566-z</ArticleId><ArticleId IdType="pmc">PMC9287327</ArticleId><ArticleId IdType="pubmed">35840571</ArticleId></ArticleIdList></Reference><Reference><Citation>Eshed Y, Feinberg K, Poliak S, Sabanay H, Sarig-Nadir O, Spiegel I, Bermingham JR, Peles E, 2005. Gliomedin mediates Schwann cell-axon interaction and the molecular assembly of the nodes of Ranvier. Neuron. 47 (2), 215&#x2013;229. 10.1016/j.neuron.2005.06.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2005.06.026</ArticleId><ArticleId IdType="pubmed">16039564</ArticleId></ArticleIdList></Reference><Reference><Citation>Gershon RC, Wagster MV, Hendrie HC, Fox NA, Cook KF, Nowinski CJ, 2013. NIH toolbox for assessment of neurological and behavioral function. Neurology 80 (11 Suppl 3), S2&#x2013;S6. 10.1212/WNL.0b013e3182872e5f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182872e5f</ArticleId><ArticleId IdType="pmc">PMC3662335</ArticleId><ArticleId IdType="pubmed">23479538</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Franquesa A, Stocks B, Chubanava S, Hattel HB, Moreno-Justicia R, Peijs L, Treebak JT, Zierath JR, Deshmukh AS, 2021. Mass-spectrometry-based proteomics reveals mitochondrial supercomplexome plasticity. Cell Reports 35 (8), 109180. 10.1016/j.celrep.2021.109180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109180</ArticleId><ArticleId IdType="pubmed">34038727</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottschalk CG, Peterson D, Armstrong J, Knox K, Roy A, 2023. Potential molecular mechanisms of chronic fatigue in long haul COVID and other viral diseases. Infect. Agent Cancer 18 (1), 7. 10.1186/s13027-023-00485-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13027-023-00485-z</ArticleId><ArticleId IdType="pmc">PMC9902840</ArticleId><ArticleId IdType="pubmed">36750846</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EL, Clark JR, Orban ZS, Lim PH, Szymanski AL, Taylor C, DiBiase RM, Jia DT, Balabanov R, Ho SU, Batra A, Liotta EM, Koralnik IJ, 2021. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 &#x201c;long haulers&#x201d;. Ann. Clin. Transl. Neurol 8 (5), 1073&#x2013;1085. 10.1002/acn3.51350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson BA, Visvabharathy L, Ali ST, Kang AK, Patel TR, Clark JR, Lim PH, Orban ZS, Hwang SS, Mattoon D, Batra A, Liotta EM, Koralnik IJ, 2022. Plasma biomarkers of neuropathogenesis in hospitalized patients with COVID-19 and those with postacute sequelae of SARS-CoV-2 infection. Neurol. Neuroimmunol. Neuroinflamm 9 (3), e1151. 10.1212/NXI.0000000000001151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001151</ArticleId><ArticleId IdType="pmc">PMC8901169</ArticleId><ArticleId IdType="pubmed">35256481</ArticleId></ArticleIdList></Reference><Reference><Citation>He J, Ma M, Li D, et al., 2021. Sulfiredoxin-1 attenuates injury and inflammation in acute pancreatitis through the ROS/ER stress/Cathepsin B axis. Cell Death Dis. 12 (7), 626. 10.1038/s41419-021-03923-l.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-021-03923-l</ArticleId><ArticleId IdType="pmc">PMC8211864</ArticleId><ArticleId IdType="pubmed">34140464</ArticleId></ArticleIdList></Reference><Reference><Citation>HealthMeasures. NIH Toolbox Measure Development and Research. 3/27/2023 2023.</Citation></Reference><Reference><Citation>Heaton RK, Akshoomoff N, Tulsky D, Mungas D, Weintraub S, Dikmen S, Beaumont J, Casaletto KB, Conway K, Slotkin J, Gershon R, 2014. Reliability and validity of composite scores from the NIH Toolbox Cognition Battery in adults. J. Int. Neuropsychol. Soc 20 (6), 588&#x2013;598. 10.1017/S1355617714000241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1355617714000241</ArticleId><ArticleId IdType="pmc">PMC4103963</ArticleId><ArticleId IdType="pubmed">24960398</ArticleId></ArticleIdList></Reference><Reference><Citation>Koralnik IJ, Tyler KL, 2020. COVID-19: A global threat to the nervous system. Ann. Neurol 88 (1), 1&#x2013;11. 10.1002/ana.25807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25807</ArticleId><ArticleId IdType="pmc">PMC7300753</ArticleId><ArticleId IdType="pubmed">32506549</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai J-S, Celia D, Choi S, Junghaenel DU, Christodoulou C, Gershon R, Stone A, 2011. How item banks and their application can influence measurement practice in rehabilitation medicine: a PROMIS fatigue item bank example. Arch. Phys. Med. Rehab 92 (10), S20&#x2013;S27. 10.1016/j.apmr.2010.08.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2010.08.033</ArticleId><ArticleId IdType="pmc">PMC3696589</ArticleId><ArticleId IdType="pubmed">21958919</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai J-S, Wagner LI, Jacobsen PB, Cella D, 2014. Self-reported cognitive concerns and abilities: two sides of one coin? Psychooncology 23 (10), 1133&#x2013;1141. 10.1002/pon.3522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pon.3522</ArticleId><ArticleId IdType="pmc">PMC4185008</ArticleId><ArticleId IdType="pubmed">24700645</ArticleId></ArticleIdList></Reference><Reference><Citation>LaSalle TJ, Gonye ALK, Freeman SS, Kaplonek P, Gushterova I, Kays KR, Manakongtreecheep K, Tantivit J, Rojas-Lopez M, Russo BC, Sharma N, Thomas MF, Lavin-Parsons KM, Lilly BM, Mckaig BN, Charland NC, Khanna HK, Lodenstein CL, Margolin JD, Blaum EM, Lirofonis PB, Revach O-Y, Mehta A, Sonny A, Bhattacharyya RP, Parry BA, Goldberg MB, Alter G, Filbin MR, Villani A-C, Hacohen N, Sade-Feldman M, 2022. Longitudinal characterization of circulating neutrophils uncovers phenotypes associated with severity in hospitalized COVID-19 patients. Cell Rep. Med 3 (10), 100779 10.1016/j.xcrm.2022.100779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100779</ArticleId><ArticleId IdType="pmc">PMC9510054</ArticleId><ArticleId IdType="pubmed">36208629</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J-S, Han D, Kim SY, Hong KH, Jang M-J, Kim MJ, Kim Y-G, Park JH, Cho SI, Park WB, Lee KB, Shin HS, Oh HS, Kim TS, Park SS, Seong M-W, 2021. Longitudinal proteomic profiling provides insights into host response and proteome dynamics in COVID-19 progression. Proteomics 21 (11-12), e2000278. 10.1002/pmic.202000278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.202000278</ArticleId><ArticleId IdType="pmc">PMC8206655</ArticleId><ArticleId IdType="pubmed">33945677</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee I, Huttemann M, Liu J, Grossman LI, Malek MH, 2012. Deletion of heart-type cytochrome c oxidase subunit 7a1 impairs skeletal muscle angiogenesis and oxidative phosphorylation. J. Physiol 590 (20), 5231&#x2013;5243. 10.1113/jphysiol.2012.239707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2012.239707</ArticleId><ArticleId IdType="pmc">PMC3497574</ArticleId><ArticleId IdType="pubmed">22869013</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, He P, Wang X-L, Zhang S, Devejian N, Bennett E, Cai C, 2018.Sulfiredoxin-1 enhances cardiac progenitor cell survival against oxidative stress via the upregulation of the ERK/NRF2 signal pathway. Free Radical Biol. Med 123, 8&#x2013;19. 10.1016/j.freeradbiomed.2018.05.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2018.05.060</ArticleId><ArticleId IdType="pmc">PMC5999586</ArticleId><ArticleId IdType="pubmed">29772252</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Schneider AM, Mehta A, et al., 2021. SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes. J. Clin. Invest 131 (13) 10.1172/JCI148635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI148635</ArticleId><ArticleId IdType="pmc">PMC8245177</ArticleId><ArticleId IdType="pubmed">34196300</ArticleId></ArticleIdList></Reference><Reference><Citation>McLeish KR, Shrestha R, Vashishta A, Rane MJ, Barati MT, Brier ME, Lau MG, Hu X, Chen O, Wessel CR, Spalding T, Bush SE, Ijemere K, Hopkins CD, Cooke EA, Tandon S, Manning T, Uriarte SM, Huang J, Yan J, 2022. Differential functional responses of neutrophil subsets in severe COVID-19 patients. Front. Immunol 13, 879686 10.3389/fimmu.2022.879686.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.879686</ArticleId><ArticleId IdType="pmc">PMC9197482</ArticleId><ArticleId IdType="pubmed">35711435</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra A, Saxena S, Kaushal A, Nagaraju G, 2018. RAD51C/XRCC3 facilitates mitochondrial DNA replication and maintains integrity of the mitochondrial genome. Mol. Cell. Biol 38 (3) 10.1128/MCB.00489-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00489-17</ArticleId><ArticleId IdType="pmc">PMC5770535</ArticleId><ArticleId IdType="pubmed">29158291</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno Fernandez-Ayala DJ, Navas P, Lopez-Lluch G, 2020. Age-related mitochondrial dysfunction as a key factor in COVID-19 disease. Exp. Gerontol 142, 111147 10.1016/j.exger.2020.111147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2020.111147</ArticleId><ArticleId IdType="pmc">PMC7648491</ArticleId><ArticleId IdType="pubmed">33171276</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunn AVW, Guy GW, Brysch W, Bell JD, 2022. Understanding long COVID; mitochondrial health and adaptation-old pathways, new problems. Biomedicines 10 (12). 10.3390/biomedicinesl0123113.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicinesl0123113</ArticleId><ArticleId IdType="pmc">PMC9775339</ArticleId><ArticleId IdType="pubmed">36551869</ArticleId></ArticleIdList></Reference><Reference><Citation>Panico P, Ostrosky-Wegman P, Salazar AM, 2022. The potential role of COVID-19 in the induction of DNA damage. Mutat. Res. Rev. Mutat. Res 789, 108411 10.1016/j.mrrev.2022.108411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mrrev.2022.108411</ArticleId><ArticleId IdType="pmc">PMC8767986</ArticleId><ArticleId IdType="pubmed">35690420</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deeks SG, Mustapic M, Kapogiannis D, Henrich TJ, Lu S, Goldberg SA, Hoh R, Chen JY, Martinez EO, Kelly JD, Martin JN, Goetzl EJ, 2022. SARS-CoV-2 and mitochondrial proteins in neural-derived exosomes of COVID-19. Ann. Neurol 91 (6), 772&#x2013;781. 10.1002/ana26350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana26350</ArticleId><ArticleId IdType="pmc">PMC9082480</ArticleId><ArticleId IdType="pubmed">35285072</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez Giraldo GS, Ali ST, Kang AK, et al., 2023. Neurologic manifestations of long COVID differ based on acute COVID-19 severity. Ann. Neurol 10.1002/ana.26649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26649</ArticleId><ArticleId IdType="pmc">PMC10724021</ArticleId><ArticleId IdType="pubmed">36966460</ArticleId></ArticleIdList></Reference><Reference><Citation>Picca A, Guerra F, Calvani R, et al., 2020. Mitochondrial signatures in circulating extracellular vesicles of older adults with Parkinson&#x2019;s disease: results from the EXosomes in PArkiNson&#x2019;s disease (EXPAND) Study. J. Clin. Med 9 (2) 10.3390/jcm9020504.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9020504</ArticleId><ArticleId IdType="pmc">PMC7074517</ArticleId><ArticleId IdType="pubmed">32059608</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzamiglio C, Machado PM, Thomas RH, Gorman GS, McFarland R, Hanna MG, Pitceathly RDS, 2022. COVID-19-related outcomes in primary mitochondrial diseases: an international study. Neurology 98 (14), 576&#x2013;582. 10.1212/WNL.0000000000200240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000200240</ArticleId><ArticleId IdType="pmc">PMC8992603</ArticleId><ArticleId IdType="pubmed">35190464</ArticleId></ArticleIdList></Reference><Reference><Citation>Probst B, Rock R, Gessler M, Vortkamp A, Puschel AW, 2007. The rodent Four-jointed ortholog Fjx1 regulates dendrite extension. Dev. Biol 312 (1), 461&#x2013;470. 10.1016/j.ydbio.2007.09.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ydbio.2007.09.054</ArticleId><ArticleId IdType="pubmed">18028897</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohloff JC, Gelinas AD, Jarvis TC, Ochsner UA, Schneider DJ, Gold L, Janjic N, 2014. Nucleic acid ligands with protein-like side chains: modified aptamers and their use as diagnostic and therapeutic agents. Mol. Ther. - Nucleic Acids 3, e201. 10.1038/mtna.2014.49.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mtna.2014.49</ArticleId><ArticleId IdType="pmc">PMC4217074</ArticleId><ArticleId IdType="pubmed">25291143</ArticleId></ArticleIdList></Reference><Reference><Citation>Saheb Sharif-Askari N, Saheb Sharif-Askari F, Ahmed SBM, Hannawi S, Hamoudi R, Hamid Q, Halwani R, 2021. Enhanced expression of autoantigens during SARS-CoV-2 viral infection. Front Immunol. 12, 686462 10.3389/fimmu.2021.686462.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.686462</ArticleId><ArticleId IdType="pmc">PMC8278821</ArticleId><ArticleId IdType="pubmed">34276672</ArticleId></ArticleIdList></Reference><Reference><Citation>Shenoy S, 2020. Coronavirus (Covid-19) sepsis: revisiting mitochondrial dysfunction in pathogenesis, aging, inflammation, and mortality. Inflamm. Res 69 (11), 1077&#x2013;1085. 10.1007/s00011-020-01389-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-020-01389-z</ArticleId><ArticleId IdType="pmc">PMC7410962</ArticleId><ArticleId IdType="pubmed">32767095</ArticleId></ArticleIdList></Reference><Reference><Citation>Stojkovic G, Makarova AV, Wanrooij PH, Forslund J, Burgers PM, Wanrooij S, 2016. Oxidative DNA damage stalls the human mitochondrial replisome. Sci. Rep 6, 28942 10.1038/srep28942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep28942</ArticleId><ArticleId IdType="pmc">PMC4929447</ArticleId><ArticleId IdType="pubmed">27364318</ArticleId></ArticleIdList></Reference><Reference><Citation>Suvarna K, Biswas D, Pai MGJ, Acharjee A, Bankar R, Palanivel V, Salkar A, Verma A, Mukherjee A, Choudhury M, Ghantasala S, Ghosh S, Singh A, Banerjee A, Badaya A, Bihani S, Loya G, Mantri K, Burli A, Roy J, Srivastava A, Agrawal S, Shrivastav O.m., Shastri J, Srivastava S, 2021. Proteomics and machine learning approaches reveal a set of prognostic markers for COVID-19 severity with drug repurposing potential. Front. Physiol 12, 652799 10.3389/iphys.2021.652799.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/iphys.2021.652799</ArticleId><ArticleId IdType="pmc">PMC8120435</ArticleId><ArticleId IdType="pubmed">33995121</ArticleId></ArticleIdList></Reference><Reference><Citation>Taniike M, Mohri I, Eguchi N, Beuckmann CT, Suzuki K, Urade Y, 2002. Perineuronal oligodendrocytes protect against neuronal apoptosis through the production of lipocalin-type prostaglandin D synthase in a genetic demyelinating model. J Neurosci. 22 (12), 4885&#x2013;4896. 10.1523/JNEUROSCI.22-12-04885.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.22-12-04885.2002</ArticleId><ArticleId IdType="pmc">PMC6757748</ArticleId><ArticleId IdType="pubmed">12077186</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Harrison PJ, 2022. Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections. Brain Behav. Immun 103, 154&#x2013;162. 10.1016/j.bbi.2022.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2022.04.013</ArticleId><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>Trahtemberg U, Fritzler MJ, Rottapel R, dos Santos CC, Di Battista AP, Slutsky AS, Baker AJ, 2021. On behalf of the C-cotLBiLIsg. COVID-19-associated autoimmunity as a feature of acute respiratory failure. Intensive Care Med. 47 (7), 801&#x2013;804. 10.1007/s00134-021-06408-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-021-06408-z</ArticleId><ArticleId IdType="pmc">PMC8084710</ArticleId><ArticleId IdType="pubmed">33928414</ArticleId></ArticleIdList></Reference><Reference><Citation>Villar M, Urra JM, Rodr&#xed;guez-del-R&#xed;o FJ, Artigas-Jer&#xf3;nimo S, Jim&#xe9;nez-Collados N, Ferreras-Colino E, Contreras M, de Mera IGF, Estrada-Pe&#xf1;a A, Gort&#xe1;zar C, de la Fuente J, 2021. Characterization by quantitative serum proteomics of immune-related prognostic biomarkers for COVID-19 symptomatology. Front. Immunol 12, 730710 10.3389/fimmu.2021.730710.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.730710</ArticleId><ArticleId IdType="pmc">PMC8457011</ArticleId><ArticleId IdType="pubmed">34566994</ArticleId></ArticleIdList></Reference><Reference><Citation>Visvabharathy L, Orban ZS, Koralnik IJ, 2022. Case report: Treatment of long COVID with a SARS-CoV-2 antiviral and IL-6 blockade in a patient with rheumatoid arthritis and SARS-CoV-2 antigen persistence. Front. Med. (Lausanne) 9, 1003103. 10.3389/ftned.2022.1003103.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/ftned.2022.1003103</ArticleId><ArticleId IdType="pmc">PMC9537824</ArticleId><ArticleId IdType="pubmed">36213654</ArticleId></ArticleIdList></Reference><Reference><Citation>Visvabharathy L, Hanson BA, Orban ZS, Lim PH, Palacio NM, Jimenez M, Clark JR, Graham EL, Liotta EM, Tachas G, Penaloza-MacMaster P, Koralnik IJ. Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARS-CoV-2 Nucleocapsid protein. Front Immunol. 2023. May 29;14:1155770. doi:10.3389/fimmu.2023.1155770. Erratum in: Front Immunol. 2023 Aug 24;14:1275925.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1155770</ArticleId><ArticleId IdType="pmc">PMC10258318</ArticleId><ArticleId IdType="pubmed">37313412</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang RC, Gottlieb M, Montoy JCC, et al., 2023. Association between SARS-CoV-2 variants and frequency of acute symptoms: analysis of a multi-institutional prospective cohort study-December 20, 2020-June 20, 2022. Open Forum Infect Dis. 10 (7), ofad275 10.1093/ofid/ofad275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofad275</ArticleId><ArticleId IdType="pmc">PMC10327880</ArticleId><ArticleId IdType="pubmed">37426947</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EY, Mao T, Klein J, et al., 2021. Diverse functional autoantibodies in patients with COVID-19. Nature 595 (7866), 283&#x2013;288. 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinberg SE, Sena LA, Chandel NS, 2015. Mitochondria in the regulation of innate and adaptive immunity. Immunity 42 (3), 406&#x2013;417. 10.1016/j.immuni.2015.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2015.02.002</ArticleId><ArticleId IdType="pmc">PMC4365295</ArticleId><ArticleId IdType="pubmed">25786173</ArticleId></ArticleIdList></Reference><Reference><Citation>Weintraub S, Dikmen SS, Heaton RK, Tulsky DS, Zelazo PD, Bauer PJ, Carlozzi NE, Slotkin J, Blitz D, Wallner-Allen K, Fox NA, Beaumont JL, Mungas D, Nowinski CJ, Richler J, Deocampo JA, Anderson JE, Manly JJ, Borosh B, Havlik R, Conway K, Edwards E, Freund L, King JW, Moy C, Witt E, Gershon RC, 2013. Cognition assessment using the NIH Toolbox. Neurology 80 (Issue 11, Supplement 3), S54&#x2013;S64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3662346</ArticleId><ArticleId IdType="pubmed">23479546</ArticleId></ArticleIdList></Reference><Reference><Citation>Weintraub S, Dikmen SS, Heaton RK, Tulsky DS, Zelazo PD, Slotkin J, Carlozzi NE, Bauer PJ, Wallner-Allen K, Fox N, Havlik R, Beaumont JL, Mungas D, Manly JJ, Moy C, Conway K, Edwards E, Nowinski CJ, Gershon R, 2014. The cognition battery of the NIH toolbox for assessment of neurological and behavioral function: validation in an adult sample. J. Int. Neuropsychol. Soc 20 (6), 567&#x2013;578. 10.1017/S1355617714000320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1355617714000320</ArticleId><ArticleId IdType="pmc">PMC4103959</ArticleId><ArticleId IdType="pubmed">24959840</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams SA, Ganz P, 2022. Response to comment on &#x201c;A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk&#x201d;. Sci. Transl. Med 14 (665), eadd1355 10.1126/scitranslmed.addl355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.addl355</ArticleId><ArticleId IdType="pubmed">36197965</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu M, Chen Y, Xia H, Wang C, Tan CY, Cai X, Liu Y, Ji F, Xiong P, Liu R, Guan Y, Duan Y, Kuang D, Xu S, Cai H, Xia Q, Yang D, Wang M-W, Chiu IM, Cheng C, Ahern PP, Liu L, Wang G, Surana NK, Xia T, Kasper DL, 2020. Transcriptional and proteomic insights into the host response in fatal COVID-19 cases. Proc. Natl. Acad. Sci. U. S. A 117 (45), 28336&#x2013;28343. 10.1073/pnas.2018030117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2018030117</ArticleId><ArticleId IdType="pmc">PMC7668053</ArticleId><ArticleId IdType="pubmed">33082228</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, Feng T, Zhou L, Tang W, Zhan L.i., Fu X, Liu S, Bo X, Yu G, 2021. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation (Camb.) 2 (3), 100141. 10.1016/j.xinn.2021.100141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xinn.2021.100141</ArticleId><ArticleId IdType="pmc">PMC8454663</ArticleId><ArticleId IdType="pubmed">34557778</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>